TY - JOUR
T1 - Molecular pathology of expanded polyalanine tract mutations in the Aristaless-related homeobox gene
AU - Shoubridge, Cheryl
AU - Cloosterman, Desiree
AU - Parkinson-Lawerence, Emma
AU - Brooks, Douglas
AU - Gécz, Jozef
N1 - Funding Information:
The authors thank May Tan for assistance in the production of mutagenic ARX homeodomain constructs and Kate Dowling of the Faculty of Health Sciences, University of Adelaide for assistance with statistical analysis of the data. Desiree Cloosterman was supported by M.S. McLeod Post-graduate Scholarship. This work was supported by a NHMRC program grant.
PY - 2007/7
Y1 - 2007/7
N2 - The Aristaless-related homeobox gene (ARX) is one of the major genes causing X-linked mental retardation. We have been interested in the pathogenic mechanism of expanded polyalanine tract mutations in ARX. We showed that the c.304ins(GCG)7 mutation causing an increase from 16 to 23 alanines increased the propensity of ARX protein aggregation and a shift from nuclear to cytoplasmic localization. We proposed that mislocalization of ARX via cytoplasmic aggregation and subsequent degradation leads to a partial loss of function, contributing to the pathogenesis. We identified importin 13 (IPO13), a mediator of nuclear import for a variety of proteins, as a novel ARX interacting protein. We predicted that the transport of ARX by IPO13 from the cytoplasm to the nucleus might be disrupted by expanded polyalanine tract mutations, but our data showed that in both yeast and mammalian cells these mutant ARX proteins were still able to interact with IPO13. We established the nuclear localization regions of the ARX homeodomain that were required for the interaction with IPO13 and correct localization of the full-length ARX transcription factor to the nucleus. Crown
AB - The Aristaless-related homeobox gene (ARX) is one of the major genes causing X-linked mental retardation. We have been interested in the pathogenic mechanism of expanded polyalanine tract mutations in ARX. We showed that the c.304ins(GCG)7 mutation causing an increase from 16 to 23 alanines increased the propensity of ARX protein aggregation and a shift from nuclear to cytoplasmic localization. We proposed that mislocalization of ARX via cytoplasmic aggregation and subsequent degradation leads to a partial loss of function, contributing to the pathogenesis. We identified importin 13 (IPO13), a mediator of nuclear import for a variety of proteins, as a novel ARX interacting protein. We predicted that the transport of ARX by IPO13 from the cytoplasm to the nucleus might be disrupted by expanded polyalanine tract mutations, but our data showed that in both yeast and mammalian cells these mutant ARX proteins were still able to interact with IPO13. We established the nuclear localization regions of the ARX homeodomain that were required for the interaction with IPO13 and correct localization of the full-length ARX transcription factor to the nucleus. Crown
KW - ARX
KW - Coimmunoprecipitation
KW - Mutation
KW - Nuclear localization sequence
KW - Polyalanine tract
KW - X-linked mental retardation
KW - Yeast-2 hybrid
UR - https://www.scopus.com/pages/publications/34250174769
U2 - 10.1016/j.ygeno.2007.03.005
DO - 10.1016/j.ygeno.2007.03.005
M3 - Article
C2 - 17490853
AN - SCOPUS:34250174769
SN - 0888-7543
VL - 90
SP - 59
EP - 71
JO - Genomics
JF - Genomics
IS - 1
ER -